TOLREMO Board of Directors Gallery — TOLREMO therapeutics: …
Currently, he is Board Chair at Chimerix, Inc. and Board Director at Werewolf Therapeutics. He previously led Chimerix as CEO, transitioning its focus from antivirals to oncology, and was …
TOLREMO Scientific Advisory Board Gallery — TOLREMO …
Dr. Alan Sandler is a distinguished leader in oncology and drug development with extensive experience in both industry and academia. His expertise spans clinical development and …
TOLREMO Strengthens Scientific Advisory Board with Lung Cancer …
Basel, March 25, 2025 – TOLREMO therapeutics AG (TOLREMO) today announced the appointment of Pasi A. Jänne, M.D., PhD, a world renowned translational thoracic medical …
TOLREMO Appoints Industry Veterans Jeff Jonker and Mike …
Basel, March 21, 2024 – TOLREMO therapeutics AG (TOLREMO) today announced the appointment of Jeff Jonker and Mike Sherman to its Board of Directors. Both bring extensive …
TOLREMO therapeutics Announces Strengthening of Leadership: …
Jun 18, 2025 · Alessandra Cesano, MD, PhD, who has served as Consulting Chief Medical Officer since April 2023, will join the company’s Board of Directors. Florian D. Vogl, MD, PhD, …
TOLREMO therapeutics Welcomes Multiple Myeloma Leader …
Basel, October 30, 2025 – TOLREMO therapeutics AG (TOLREMO) today announced the appointment of Kenneth C. Anderson, MD, a globally recognized leader in multiple myeloma …
News & Events — TOLREMO therapeutics: Stopping Non-genetic …
TOLREMO THERAPEUTICS ANNOUNCES STRENGTHENING OF LEADERSHIP: ALESSANDRA CESANO JOINS BOARD OF DIRECTORS, FLORIAN D. VOGL APPOINTED …
Exclusive Cancer Research Press Releases — TOLREMO …
Oct 30, 2025 · "Joining TOLREMO's board is an opportunity to contribute to a company making significant strides toward surmounting a universal problem for current and future targeted …
TOLREMO Welcomes Dr. Alan Sandler to Scientific Advisory Board
May 8, 2024 · “I have been impressed with TOLREMO’s work. The team has discovered an exciting pivotal mechanism that governs critical transcriptional resistance pathways,” said Alan …
TOLREMO Leadership Gallery — TOLREMO therapeutics: Stopping …
Jessica serves on the board of directors at RS Oncology, a clinical-stage biotech company. She holds an M.B.A. from the UCLA Anderson School of Management and a B.S. in Biology from …